What is Biolytic Lab Performance?
Biolytic Lab Performance, Inc. is a key player in the development and manufacturing of sophisticated DNA, RNA, and peptide oligonucleotide synthesizers. The company serves a critical need for researchers and laboratories requiring reliable, high-throughput synthesis solutions. Their product portfolio encompasses a range of synthesizers designed for low, medium, and high throughput applications, complemented by essential synthesis consumables and accessories. Beyond hardware, Biolytic Lab Performance offers robust support services, including instrument maintenance, user training, and hardware qualifications, ensuring comprehensive assistance for their clientele in the life sciences and biotechnology sectors.
How much funding has Biolytic Lab Performance raised?
Biolytic Lab Performance has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Biolytic Lab Performance
PPP
Public-Private Partnership
What's next for Biolytic Lab Performance?
With substantial late-stage capital infusion, Biolytic Lab Performance is poised for significant expansion and further innovation in oligonucleotide synthesis technology. This strategic investment is expected to fuel advancements in their product development, potentially broadening their market reach into new research areas and increasing manufacturing capacity to meet growing global demand. The company's focus on providing end-to-end solutions, from instrumentation to ongoing support, positions it for sustained growth and leadership in the competitive biotechnology research tools landscape.
See full Biolytic Lab Performance company page
